ناقشت
بنجاح طالبة الماجستير رنا عزمي راغب ملحيس من قسم الصيدلة السريرية يوم الأربعاء
الموافق 16/12/2015م بعنوان " التكلفة الطبية المباشرة لمرض سرطان القولون والمستقيم
في شمال الأردن "
وقد
ضمت لجنة المناقشة الدكتور قيس العيفان رئيساً وعضوية كل من الدكتور نزار مهيدات
والأستاذ الدكتور كارم الزعبي والدكتورة ميرا العبابنة والدكتور فارس الدحيات كممتحن
خارجي.
باسم
صفحة أصدقاء كلية الصيدلة_ في جامعة العلوم والتكنولوجيا الأردنية نبارك للطالبة
رنا ملحيس إتمامها درجة الماجستير في الصيدلة السريرية بنجاح وتفوق متمنين لها
مزيدا من التقدم.
*
للاطلاع على ملخص الدراسة:
Background: Colorectal cancer (CRC) includes
cancerous growths in the colon and rectum. Globally, it is the fourth most
commonly diagnosed cancer causing 655,000 deaths worldwide per year. In Jordan,
CRC is the most common cancer in men and the second in women. whereas health
care systems all over the world are struggling with the dilemma of limited
resources and growing needs, estimates of the costs associated with CRC care
are essential both for assessing burden of the disease at the population level
and for conducting economic evaluations of interventions to prevent, detect, or
treat CRC. Direct medical cost is related to resources that are directly used
in treating the patient such as the cost of drugs, diagnostic, treatment,
follow up, rehabilitation and hospital admission. In addition to the cost of
treating side effects. This study aimed to estimate and analyze the direct
medical costs attributable to CRC in North of Jordan.
Methods: A retrospective analysis of a cohort of all patients treated for CRC in KAUH has been performed to determine the direct medical costs attributable to CRC in North of Jordan. Demographic, Statistical analysis was conducted using SPSSTM for Windows and a p value of clinical, and economic data has been collected and entered into Excel. < 0.05 was defined as statistically significant.
Results: This study quantified the direct medical cost associated with CRC by all treated patients in KAUH from the perspective of health care providers (public sector). It included 97 patients, of which males were 52 (53.6%). The mean age was 57.31 ±13.3. A total of 63 patients presented at stage 4. Total CRC cancer cost in the year 2014 in KAUH patients had colon as a primary site of tumor (65%), and more than 50% of was estimated to JD 695,608. In addition, the most expensive stage for all Mann-Whitney tests for comparison between all stages and primary sites of tumor sites was stage 4 reaching a cost of JD 518,894. Using Kruskal-Wallis and effect on total cost; statistically significant differences in between stages differences were found in median costs per patient between sites. Most of the cost was found (p value < 0.05). Advanced disease stages were associated with a higher total cost, and chemotherapy costs, and a decrease in the relative weight of surgical costs. While, no statistically significant an economic burden on health care services in Jordan. The earlier the stage of total cost of the disease was attributable to drugs (chemotherapy mainly) followed by laboratory tests and follow up procedures. Conclusion CRC creates CRC, the less is the cost. More efforts should be done for improving the stages, which corresponded to high cost.
awareness of CRC since most of the patients were presented in the advanced stages, which corresponded to high cost.
ليست هناك تعليقات:
إرسال تعليق